Want to lower your risk of dementia? It doesn’t involve a blood test

The proposed Alzheimer’s Screening and Prevention Act positions a federal framework for dementia risk reduction that does not depend on blood testing, offering a direct policy lever for those fearing cognitive decline. By shifting focus to early screening and lifestyle interventions, the legislation promises to protect at‑risk adults and could reduce future healthcare costs tied to Alzheimer’s care. Coverage notes that while Medical Xpress highlights blood and gene tests capable of flagging symptoms three to six years early, Associated Press stories stress that lowering dementia risk can be achieved without such tests.

RealClearHealth and the Post Bulletin amplify calls for congressional backing of the bill, framing it as a preventive alternative to laboratory diagnostics. Older adults, their families, and the health system stand to benefit if Congress embraces the proposal, as the Post Bulletin letter makes clear the bill still needs legislative support. The next step is a congressional vote; progress will be tracked through further statements from lawmakers and updates from health policy outlets.

Monitoring will come from health policy analysts and future Reuters updates as the measure proceeds through committees.